BSE
Your Result on : Company News
Cohance Lifesciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value (Rs)
115.2528864
NSE Symbol
COHANCE
Divident Yield %
0
Market Cap
(Rs In Cr.)
11,772
P/E (TTM)
34.81
EPS (TTM)
8.84
Face Value
(Rs)
1
Date Heading
13-Feb-26 Cohance Lifesciences consolidated net profit declines 76.01% in the De
07-Feb-26 Cohance Lifesciences receives warning letter from USFDA for its Hydera
04-Feb-26 Cohance Lifesciences receives warning letter for its Nacharam formulat
30-Dec-25 Cohance Lifesciences to convene board meeting
13-Nov-25 Cohance Lifesciences consolidated net profit declines 46.50% in the Se
13-Nov-25 Cohance Lifesciences Ltd leads losers in 'A' group
13-Nov-25 Cohance Lifesciences drops after Q2 PAT slumps 46% YoY to Rs 74 cr
29-Oct-25 IIFL Capital Services Ltd leads losers in 'A' group
29-Oct-25 Volumes soar at Blue Dart Express Ltd counter
29-Oct-25 Cohance Lifesciences' MD V Prasada Raju resigns
23-Oct-25 Volumes soar at Vardhman Textiles Ltd counter
08-Oct-25 Cohance Lifesciences Ltd - Compliances-Certificate under Reg. 74 (5) o
08-Oct-25 Cohance Lifesciences Ltd - Cohance Lifesciences Limited - Certificate
30-Sep-25 Cohance Lifesciences to discuss results
29-Sep-25 Cohance Lifesciences Ltd - Cohance Lifesciences Limited - Trading Wind
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)